M
M-G Franzosi
Publications - 1
Citations - 108
M-G Franzosi is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Contraindication. The author has an hindex of 1, co-authored 1 publications receiving 104 citations.
Papers
More filters
Journal ArticleDOI
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
Active W Investigators,Stuart J. Connolly,Salim Yusuf,A Budaj,John Camm,Susan Chrolavicius,Patrick J. Commerford,Marcus Flather,Keith A.A. Fox,Robert G. Hart,S H Hohnloser,Campbell D. Joyner,Marc A. Pfeffer,Inderjit Anand,Heather M. Arthur,A Avezum,M Bethala-Sithya,Mel Blumenthal,L Ceremuzynski,R. De Caterina,Rafael Diaz,Gregory C. Flaker,G Frangin,M-G Franzosi,Christophe Gaudin,Sergey P. Golitsyn,Samuel Z. Goldhaber,Christopher B. Granger,David A. Halon,Antonio G. Hermosillo,David M. Hunt,Petr Jansky,Nicholas Karatzas,Matyas Keltai,Fernando Lanas,C P Lau,J-Y Le Heuzey,Basil S. Lewis,João Morais,Carlos A. Morillo,Ali Oto,Ernesto Paolasso,Ron J.G. Peters,M Pfisterer,Leopoldo S. Piegas,T Pipillis,C Proste,Eva Sitkei,Karl Swedberg,David Synhorst,Mario Talajic,V Trégou,Vicent Valentin,W. Van Mieghem,William S. Weintraub,John Varigos +55 more
TL;DR: Clopidogrel plus ASA plus irbesartan will lead to a new understanding of the role of combined antiplatelet therapy and therole of blood pressure lowering with an angiotensin II receptor blocker in patients with AF.